EichorEICHOR
Study identifier: NCT07242599 Synced from ClinicalTrials.gov · August 02, 2026
● Not Yet Recruiting

Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Condition: Ischemic Cerebral Infarction  ·  Sponsor: Beijing Tiantan Hospital

PhasePhase 3
Planned participants4810
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The Oris trial aims to evaluate whether the use of Ongericimab injection in patients with atherosclerotic ischemic cerebrovascular disease within 3 months of onset can reduce the risk of recurrent major cardiovascular events by achieving lower lipid-lowering target values (LDL-C \< 1.4 mmol/L).

This description comes directly from the study's public registry record.

Talk to the study team

Yongjun Wang, MD  ·  +86 13911172565  ·  yongjunwang111@aliyun.com

Liye Dai, MD  ·  +86 15010545290  ·  yezidailiye@163.com

Always discuss trial participation with your own doctor first.

Locations (199)

Fuyang People's HospitalFuyang, Anhui, China
The First Affiliated Hospital of Wannan Medical CollegeWuhu, Anhui, China
The First Hospital of Fangshan District, BeijingBeijing, Beijing Municipality, China
Chongqing Sanbo Changan HospitalChongqing, Chongqing Municipality, China
The Fifth People's Hospital of ChongqingChongqing, Chongqing Municipality, China
The First Affiliated Hospital of Chongqing Medical and Pharmaceutical CollegeChongqing, Chongqing Municipality, China
Ningde People's HospitalNingde, Fujian, China
Minxian County Hospital of Traditional Chinese MedicineDingxi, Gansu, China
Shanghai General Hospital Jiuquan HospitalJiuquan, Gansu, China
Gansu Provincial Maternity and Child-care Hospital(Gansu Provincial Central Hospital)Lanzhou, Gansu, China
The First People's Hospital of Yuzhong CountyLanzhou, Gansu, China
First People's Hospital of TianshuiTianshui, Gansu, China

+ 187 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →